Condition
Ketosis Prone Diabetes
Total Trials
5
Recruiting
1
Active
2
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (1)
P 1 (1)
P 4 (2)
Trial Status
Completed3
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06699810Phase 4Active Not RecruitingPrimary
Modeling Ketosis-Prone Diabetes Remission Via Diverse Mechanisms of Glucotoxicity
NCT07167693Phase 1Recruiting
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
NCT03566524Not ApplicableCompletedPrimary
Study of Arginine and Nitric Oxide in Patients With Diabetes
NCT01099618Phase 4CompletedPrimary
Ketosis-Prone Diabetes Mellitus (KPDM): Metformin Versus Sitagliptin Treatment
NCT00426413CompletedPrimary
Ketosis Prone Diabetes in African-Americans
Showing all 5 trials